Bioanalytical Systems Stock Price, News & Analysis (NASDAQ:BASI)

$2.80 0.01 (0.36 %)
(As of 12/14/2017 08:15 AM ET)
Previous Close$2.79
Today's Range$2.71 - $2.85
52-Week Range$0.65 - $2.95
Volume75,600 shs
Average Volume159,636 shs
Market Capitalization$22.99 million
P/E RatioN/A
Dividend YieldN/A
Beta1.36

About Bioanalytical Systems (NASDAQ:BASI)

Bioanalytical systems, Inc. is an international contract research company providing drug discovery and development services and analytical instruments. The Company operates in two segments: contract research services and research products. The contract research services segment provides research and development support on a contract basis to pharmaceutical companies. The research products segment provides liquid chromatography, electrochemical and physiological monitoring products to pharmaceutical companies, universities, government research centers, and medical research institutions. The Company supports the preclinical and clinical development needs of researchers and clinicians for small molecule and large biomolecule drug candidates. The contract research services segment provides screening and pharmacological testing, preclinical safety testing, formulation development, regulatory compliance and quality control testing.

Receive BASI News and Ratings via Email

Sign-up to receive the latest news and ratings for BASI and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Biotechnology & Medical Research
Sub-IndustryN/A
SectorMedical
SymbolNASDAQ:BASI
CUSIPN/A
Phone765-463-4527

Debt

Debt-to-Equity Ratio0.60%
Current Ratio0.64%
Quick Ratio0.51%

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$20.44 million
Price / Sales1.13
Cash FlowN/A
Price / CashN/A
Book Value$0.77 per share
Price / Book3.64

Profitability

Trailing EPS($0.17)
Net Income$-3,230,000.00
Net Margins-5.88%
Return on Equity-20.72%
Return on Assets-6.61%

Miscellaneous

Employees151
Outstanding Shares8,240,000

Bioanalytical Systems (NASDAQ:BASI) Frequently Asked Questions

What is Bioanalytical Systems' stock symbol?

Bioanalytical Systems trades on the NASDAQ under the ticker symbol "BASI."

How were Bioanalytical Systems' earnings last quarter?

Bioanalytical Systems, Inc. (NASDAQ:BASI) released its quarterly earnings results on Thursday, August, 11th. The company reported ($0.05) EPS for the quarter. The business earned $5.05 million during the quarter, compared to analyst estimates of $6.15 million. Bioanalytical Systems had a negative net margin of 5.88% and a negative return on equity of 20.72%. View Bioanalytical Systems' Earnings History.

When will Bioanalytical Systems make its next earnings announcement?

Bioanalytical Systems is scheduled to release their next quarterly earnings announcement on Wednesday, December, 20th 2017. View Earnings Estimates for Bioanalytical Systems.

Who are some of Bioanalytical Systems' key competitors?

Who are Bioanalytical Systems' key executives?

Bioanalytical Systems' management team includes the folowing people:

  • Gregory C. Davis Ph.D., Interim Chairman of the Board
  • Jill Blumhoff, Chief Financial Officer, Vice President - Finance (Age 39)
  • James S. Bourdage Ph.D., Vice President - Bioanalytical Operations (Age 63)
  • Philip A. Downing, Vice President - Preclinical Services (Age 45)
  • Connie Dougherty, Vice President - Business Development (Age 53)
  • Richard Allen Johnson Ph.D., Independent Director (Age 70)
  • R. Matthew Neff, Independent Director
  • Wendy Perrow, Independent Director (Age 57)

How do I buy Bioanalytical Systems stock?

Shares of Bioanalytical Systems can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Bioanalytical Systems' stock price today?

One share of Bioanalytical Systems stock can currently be purchased for approximately $2.80.

How big of a company is Bioanalytical Systems?

Bioanalytical Systems has a market capitalization of $22.99 million and generates $20.44 million in revenue each year. The company earns $-3,230,000.00 in net income (profit) each year or ($0.17) on an earnings per share basis. Bioanalytical Systems employs 151 workers across the globe.

How can I contact Bioanalytical Systems?

Bioanalytical Systems' mailing address is 2701 KENT AVENUE, WEST LAFAYETTE IN, 47906. The company can be reached via phone at 765-463-4527 or via email at [email protected]


MarketBeat Community Rating for Bioanalytical Systems (BASI)

Community Ranking:  2.2 out of 5 (star star)
Outperform Votes:  34 (Vote Outperform)
Underperform Votes:  45 (Vote Underperform)
Total Votes:  79
MarketBeat's community ratings are surveys of what our community members think about Bioanalytical Systems and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Bioanalytical Systems (NASDAQ:BASI) Analyst Ratings History


No equities research coverage for this company has been tracked by MarketBeat

Earnings

Bioanalytical Systems (NASDAQ:BASI) Earnings History and Estimates Chart

Earnings by Quarter for Bioanalytical Systems (NASDAQ:BASI)

Bioanalytical Systems (NASDAQ BASI) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
12/20/2017N/AView Earnings Details
8/14/2017Q3 2017$0.03$5.84 millionViewN/AView Earnings Details
5/15/2017Q2 2017$0.05$6.36 millionViewN/AView Earnings Details
8/11/2016Q316($0.05)$6.15 million$5.05 millionViewListenView Earnings Details
5/12/2016Q216($0.03)$5.73 million$5.34 millionViewListenView Earnings Details
2/16/2016Q116($0.06)$5.95 million$4.90 millionViewListenView Earnings Details
12/17/2015Q415($0.09)$6.42 million$4.98 millionViewListenView Earnings Details
8/13/2015Q315$0.16$6.03 million$6.15 millionViewListenView Earnings Details
5/14/2015Q215($0.01)$5.92 million$5.73 millionViewListenView Earnings Details
2/12/2015Q115$0.01$6.22 million$5.85 millionViewN/AView Earnings Details
12/22/2014Q414($0.02)$6.42 millionViewN/AView Earnings Details
8/14/2014Q314$0.02$5.60 million$6.03 millionViewN/AView Earnings Details
5/15/2014Q2($0.03)$5.16 million$5.91 millionViewListenView Earnings Details
2/13/2014Q114$0.04$5.80 million$6.22 millionViewN/AView Earnings Details
12/24/2013Q4 13$0.03$6.54 million$5.51 millionViewN/AView Earnings Details
10/18/2013Q313$0.01$0.07$5.65 million$5.60 millionViewN/AView Earnings Details
5/15/2013Q2 2013$0.01($0.02)$5.74 million$5.16 millionViewListenView Earnings Details
2/14/2013Q1 2013($0.03)$0.02$6.65 million$5.80 millionViewListenView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Bioanalytical Systems (NASDAQ:BASI) Earnings Estimates

No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for Bioanalytical Systems (NASDAQ:BASI)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Bioanalytical Systems (NASDAQ BASI) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 2.50%
Institutional Ownership Percentage: 5.37%
Insider Trades by Quarter for Bioanalytical Systems (NASDAQ:BASI)

Bioanalytical Systems (NASDAQ BASI) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/8/2017R Matthew NeffDirectorBuy5,000$1.50$7,500.00View SEC Filing  
8/18/2017R Matthew NeffDirectorBuy5,000$1.70$8,500.00View SEC Filing  
5/27/2016Connie Leigh DoughertyVPBuy423$0.92$389.16View SEC Filing  
5/23/2016Connie Leigh DoughertyVPBuy96$0.92$88.32View SEC Filing  
5/19/2016Connie Leigh DoughertyVPBuy1,655$0.92$1,522.60View SEC Filing  
2/29/2016Jacqueline M LemkeCEOBuy10,000$1.18$11,800.00View SEC Filing  
9/14/2015Philip A DowningVPBuy3,000$1.73$5,190.00View SEC Filing  
2/27/2015Jacqueline M LemkeCEOBuy10,000$2.04$20,400.00View SEC Filing  
6/13/2014John P DevineVPSell3,130$2.64$8,263.20View SEC Filing  
8/17/2012David L OmachinskiDirectorBuy10,000$1.26$12,600.00View SEC Filing  
8/17/2012Jacqueline M LemkeCEOBuy20,000$1.26$25,200.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Bioanalytical Systems (NASDAQ BASI) News Headlines

Source:
DateHeadline
Bioanalytical Systems (BASI) Scheduled to Post Quarterly Earnings on WednesdayBioanalytical Systems (BASI) Scheduled to Post Quarterly Earnings on Wednesday
www.americanbankingnews.com - December 13 at 1:28 AM
BASi Announces Enhanced Bioequivalence CapabilitiesBASi Announces Enhanced Bioequivalence Capabilities
finance.yahoo.com - December 12 at 11:43 AM
What Investors Should Know About Bioanalytical Systems Inc’s (BASI) Financial StrengthWhat Investors Should Know About Bioanalytical Systems Inc’s (BASI) Financial Strength
finance.yahoo.com - November 21 at 4:53 PM
Steady Growth Spurs Plans for BASi Expansion of GLP Toxicology Facility in IndianaSteady Growth Spurs Plans for BASi Expansion of GLP Toxicology Facility in Indiana
finance.yahoo.com - November 14 at 1:35 AM
Gaining Momentum: BASi Adds Candace Rohde-Johnson as Director of in Vivo Products and ServicesGaining Momentum: BASi Adds Candace Rohde-Johnson as Director of in Vivo Products and Services
finance.yahoo.com - October 3 at 4:06 PM
Bioanalytical Systems Inc (BASI): Is Healthcare An Attractive Sector Play?Bioanalytical Systems Inc (BASI): Is Healthcare An Attractive Sector Play?
finance.yahoo.com - September 22 at 3:18 PM
BASi and JOANNEUM RESEARCH Enter Into Collaboration to Commercialize Open Flow Microperfusion TechnologyBASi and JOANNEUM RESEARCH Enter Into Collaboration to Commercialize Open Flow Microperfusion Technology
finance.yahoo.com - September 6 at 4:15 PM
Featured Company News - Myriad Genetics EndoPredict Receives Positive Coverage Decisions from Palmetto and AnthemFeatured Company News - Myriad Genetics' EndoPredict Receives Positive Coverage Decisions from Palmetto and Anthem
finance.yahoo.com - August 22 at 10:03 PM
Bioanalytical Systems, Inc. :BASI-US: Earnings Analysis: Q3, 2017 By the Numbers : August 16, 2017Bioanalytical Systems, Inc. :BASI-US: Earnings Analysis: Q3, 2017 By the Numbers : August 16, 2017
finance.yahoo.com - August 16 at 4:58 PM
Bioanalytical Systems, Inc. :BASI-US: Earnings Analysis: Q3, 2017 By the Numbers : August 16, 2017Bioanalytical Systems, Inc. :BASI-US: Earnings Analysis: Q3, 2017 By the Numbers : August 16, 2017
finance.yahoo.com - August 16 at 4:58 PM
Bioanalytical Systems, Inc. (BASI) Releases  Earnings ResultsBioanalytical Systems, Inc. (BASI) Releases Earnings Results
www.americanbankingnews.com - August 15 at 9:41 AM
BASi Reports Continued Profitability Improvement in Third QuarterBASi Reports Continued Profitability Improvement in Third Quarter
finance.yahoo.com - August 14 at 4:44 PM
BASi Announces Election of R. Matthew Neff to the Board of DirectorsBASi Announces Election of R. Matthew Neff to the Board of Directors
finance.yahoo.com - August 3 at 5:46 PM
Bioanalytical Systems, Inc. (NASDAQ:BASI) Set to Announce Earnings on WednesdayBioanalytical Systems, Inc. (NASDAQ:BASI) Set to Announce Earnings on Wednesday
www.americanbankingnews.com - August 2 at 7:20 AM
BASi Signs Reseller Agreement With LABEX of MA for Refurbished Culex(R) Automated Blood Sampling SystemsBASi Signs Reseller Agreement With LABEX of MA for Refurbished Culex(R) Automated Blood Sampling Systems
finance.yahoo.com - July 31 at 4:27 PM
Bioanalytical Systems, Inc.: BASi Names Dr. Gregory C. Davis to Board of DirectorsBioanalytical Systems, Inc.: BASi Names Dr. Gregory C. Davis to Board of Directors
www.finanznachrichten.de - June 20 at 4:31 PM
BRIEF-BASI reports Q2 earnings per share $0.05BRIEF-BASI reports Q2 earnings per share $0.05
www.reuters.com - May 17 at 12:06 PM
Q1 2017 Bioanalytical Systems Inc Earnings Release - Before Market OpenQ1 2017 Bioanalytical Systems Inc Earnings Release - Before Market Open
us.rd.yahoo.com - February 14 at 8:27 PM
BASi Reports First Quarter ResultsBASi Reports First Quarter Results
us.rd.yahoo.com - February 14 at 8:27 PM
BIOANALYTICAL SYSTEMS INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and ExhBIOANALYTICAL SYSTEMS INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exh
biz.yahoo.com - January 17 at 4:32 PM
Q4 2016 Bioanalytical Systems Inc Earnings Release - Before Market OpenQ4 2016 Bioanalytical Systems Inc Earnings Release - Before Market Open
us.rd.yahoo.com - December 22 at 3:51 PM
BIOANALYTICAL SYSTEMS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements andBIOANALYTICAL SYSTEMS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and
biz.yahoo.com - December 22 at 3:51 PM
Bioanalytical Systems Inc Earnings Call scheduled for 2:00 pm ET todayBioanalytical Systems Inc Earnings Call scheduled for 2:00 pm ET today
biz.yahoo.com - December 22 at 3:51 PM
Bioanalytical Systems Inc Earnings Call scheduled for 2:00 pm ET todayBioanalytical Systems Inc Earnings Call scheduled for 2:00 pm ET today
biz.yahoo.com - December 22 at 3:51 PM
BIOANALYTICAL SYSTEMS INC Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or SBIOANALYTICAL SYSTEMS INC Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or S
biz.yahoo.com - December 7 at 4:26 PM
BRIEF-Basi Q3 loss per share $0.05BRIEF-Basi Q3 loss per share $0.05
www.reuters.com - August 12 at 12:20 PM
BIOANALYTICAL SYSTEMS INC Files SEC form 8-K, Regulation FD DisclosureBIOANALYTICAL SYSTEMS INC Files SEC form 8-K, Regulation FD Disclosure
biz.yahoo.com - August 4 at 3:50 PM
BIOANALYTICAL SYSTEMS INC Files SEC form 8-K, Change in Directors or Principal Officers, Regulation FD DisclosureBIOANALYTICAL SYSTEMS INC Files SEC form 8-K, Change in Directors or Principal Officers, Regulation FD Disclosure
biz.yahoo.com - July 22 at 3:12 PM
BIOANALYTICAL SYSTEMS INC Files SEC form 8-K, Entry into a Material Definitive AgreementBIOANALYTICAL SYSTEMS INC Files SEC form 8-K, Entry into a Material Definitive Agreement
biz.yahoo.com - July 6 at 1:19 PM
BIOANALYTICAL SYSTEMS INC Files SEC form 8-K, Entry into a Material Definitive AgreementBIOANALYTICAL SYSTEMS INC Files SEC form 8-K, Entry into a Material Definitive Agreement
biz.yahoo.com - July 6 at 1:19 PM
Q2 2016 Bioanalytical Systems Inc Earnings Release - Before Market OpenQ2 2016 Bioanalytical Systems Inc Earnings Release - Before Market Open
biz.yahoo.com - May 12 at 7:07 AM
BIOANALYTICAL SYSTEMS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and ExBIOANALYTICAL SYSTEMS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Ex
biz.yahoo.com - May 4 at 1:16 PM
BIOANALYTICAL SYSTEMS INC Files SEC form 8-K, Submission of Matters to a Vote of Security HoldersBIOANALYTICAL SYSTEMS INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders
biz.yahoo.com - March 16 at 3:52 PM

SEC Filings

Bioanalytical Systems (NASDAQ:BASI) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Bioanalytical Systems (NASDAQ:BASI) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Bioanalytical Systems (NASDAQ BASI) Stock Chart for Thursday, December, 14, 2017

Loading chart…

This page was last updated on 12/14/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.